DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Cara Therapeutics, Inc. (CARA)
« Back to company indexCARA Chatter Timeline
Stock Ticker for CARA
Most Active Tweeters for CARA
| User | Tweets |
|---|---|
| @OlympiaReport | 6 |
| @ConsumerFeed | 4 |
| @dispatchtribune | 4 |
| @whatsonthorold2 | 4 |
| @WeekHerald | 3 |
Recent Tweets for CARA
 |
@ConsumerFeed Cara Therapeutics $CARA Now Covered by Bank of America https://t.co/jcP3uRSMqK January 18th 2019, 5:01pm |
 |
@thefinreviewer State Street Lifted Its Stake in Cara Therapeutics $CARA by $9.44 Million as Market Value Declined; Ubiquiti Networ… https://t.co/AY5R9jDjWQ January 18th 2019, 1:01pm |
 |
@LIGBeyond $CARA watching lotta, bag-holders from $18+ January 17th 2019, 9:01am |
 |
@newswithvalue $T $CARA: Jim Cramer Weighs In On Twitter, Deutsche Bank And More: https://t.co/UPHzERWEH2 January 17th 2019, 8:01am |
 |
@OlympiaReport Zacks Investment Research Lowers Cara Therapeutics $CARA to Sell https://t.co/SKvmgL0k5F January 17th 2019, 1:01am |
|
@thefinreviewer Blb&B Advisors Raised Its Boeing Co $BA Stake; Profile of 4 Analysts Covering Cara Therapeutics, Inc. $CARA https://t.co/q2EGZADChX January 16th 2019, 11:01am |
 |
@whatsonthorold2 Is there a Bearish outlook for Cara Therapeutics, Inc. $CARA this week? https://t.co/8aX8XoTioI January 16th 2019, 9:01am |
|
@OlympiaReport Cara Therapeutics $CARA Now Covered by Bank of America https://t.co/VtvujeFsHi January 16th 2019, 9:01am |
 |
@dispatchtribune Cara Therapeutics $CARA Now Covered by Analysts at Bank of America https://t.co/LgxXtQYhHO January 16th 2019, 9:01am |
 |
@bbnsnews Cara Therapeutics $CARA Stock Rating Lowered by Zacks Investment Research https://t.co/SNYD6DtZBt January 16th 2019, 2:01am |
|
@whatsonthorold2 Cara Therapeutics $CARA Is Now Covered By BofA Merrill. What can We Expect? https://t.co/EEDyRD3c9J https://t.co/rPNrHYoVvJ January 15th 2019, 3:01pm |
 |
@mmahotstuff1 Should Cara Therapeutics $CARA Shares Be Watched After Bank of America Initiates Coverage? https://t.co/SkoHgeUyJb https://t.co/1CZjLTk6hk January 15th 2019, 2:01pm |
 |
@davidmoadel $CARA Bank Of America Takes Neutral Stance On Cara Therapeutics Ahead Of Phase 3 Korsuva Results… https://t.co/XTKv7Lmgba January 15th 2019, 1:01pm |
|
@newswithvalue $CARA: Bank Of America Takes Neutral Stance On Cara Therapeutics …: https://t.co/j1OKUx41JX January 15th 2019, 11:01am |
 |
@firsttomarkets Cara Therapeutics Inc Initiated Coverage by Bank of America (Ranked 45th) to Neutral with $19PT $CARA #CARA https://t.co/TwWCsquQWC January 15th 2019, 11:01am |
 |
@AmericanBanking Cara Therapeutics $CARA Receives New Coverage from Analysts at Bank of America https://t.co/E3tbwtM6zX #stocks January 15th 2019, 8:01am |
 |
@TheMarketsDaily Bank of America Initiates Coverage on Cara Therapeutics $CARA https://t.co/bDg9k6DAIU January 15th 2019, 8:01am |
 |
@ThisLincolnian Zacks Investment Research Lowers Cara Therapeutics $CARA to Sell https://t.co/fiPXlb1y39 January 15th 2019, 7:01am |
 |
@WeekHerald Cara Therapeutics $CARA Lowered to Sell at Zacks Investment Research https://t.co/BMnEImR4Ov January 15th 2019, 7:01am |
 |
@BioStocks $CARA initiated at Neutral at BofA/Merrill. PT $19 January 15th 2019, 6:01am |
 |
@AlexBo6 $CARA downhill ride home to 12-13 not J-hook up with that pot https://t.co/yrdvTwhFUK January 14th 2019, 8:01pm |
 |
@registrarjourn Cara Therapeutics $CARA Cut to “Sell” at Zacks Investment Research https://t.co/pnEzAIOD1x January 14th 2019, 8:01pm |
 |
@EnterpriseLeade Cara Therapeutics $CARA Cut to “Sell” at Zacks Investment Research https://t.co/DSZWu7OK5n January 14th 2019, 8:01pm |
 |
@WatchlistN Cara Therapeutics $CARA Downgraded by Zacks Investment Research to “Sell” https://t.co/1L4ehEhWwd January 12th 2019, 10:01am |
 |
@TranscriptDaily Cara Therapeutics Inc $CARA Expected to Post Quarterly Sales of $3.35 Million https://t.co/ubJZk2HAlV January 11th 2019, 9:01pm |
 |
@ChartMill $CARA has a poor technical rating and the quality of the setup is also only medium at the moment.… https://t.co/abcSUAFuBI January 11th 2019, 9:01pm |
|
@dispatchtribune Zacks Investment Research Downgrades Cara Therapeutics $CARA to Sell https://t.co/R4jsVe6G8o January 11th 2019, 1:01pm |
|
@TranscriptDaily Cara Therapeutics $CARA Downgraded by Zacks Investment Research https://t.co/BZQBPrlCfW January 11th 2019, 1:01pm |
 |
@oldtrader60 $CARA I like the V bottom on this one. At the low it traded 2X normal daily volume. This is a Pot play as well https://t.co/9NEtuLQ0dE January 11th 2019, 12:01pm |
 |
@tradingmy2cents Bought back call options on $CGC and $CARA January 11th 2019, 10:01am |
 |
@StockNewsWires $CARA $FMS: Here’s Why Cara Therapeutics Fell 28.5% in December: https://t.co/UmfSy0z5ln January 10th 2019, 9:01pm |
|
@tradingmy2cents Closed $CGC and $CARA LEAP options to lock in gain (no position) January 10th 2019, 1:01pm |
|
@OlympiaReport Zacks Investment Research Downgrades Cara Therapeutics $CARA to Sell https://t.co/iDeufGndwN January 10th 2019, 5:01am |
|
@WeekHerald Cara Therapeutics $CARA Downgraded to Sell at Zacks Investment Research https://t.co/CeMw5e0F86 January 10th 2019, 5:01am |
 |
@dakotafinancial Cara Therapeutics $CARA Lowered to “Sell” at Zacks Investment Research https://t.co/tZeOrCbJpu January 9th 2019, 1:01pm |
 |
@macondailynews Cara Therapeutics $CARA Downgraded to Sell at Zacks Investment Research https://t.co/Q3fKJwaQni January 9th 2019, 1:01pm |
|
@OlympiaReport $3.35 Million in Sales Expected for Cara Therapeutics Inc $CARA This Quarter https://t.co/0pL8bJ7V7n January 9th 2019, 12:01pm |
|
@WeekHerald $3.35 Million in Sales Expected for Cara Therapeutics Inc $CARA This Quarter https://t.co/TLWv87ZTFJ January 9th 2019, 12:01pm |
 |
@AlpacaAlerts $CARA is in Dark Cloud Cover winning 80.00% in the past. https://t.co/NSH9e0NeMQ January 9th 2019, 1:01am |
|
@ConsumerFeed Zacks Investment Research Lowers Cara Therapeutics $CARA to Sell https://t.co/TrL0YmsHvx January 8th 2019, 7:01pm |
 |
@DeepSouthDoctor Getting interested in $CARA after having quit following them past few years. Intrigued by their pipeline progress,… https://t.co/u2159f1f4G January 8th 2019, 8:01am |
 |
@MaisaCorp $CARA Completes Enrollment of Phase 3 Trial of KORSUVA in Hemodialysis Patients With Pruritus January 7th 2019, 3:01pm |
 |
@SwingTradeBot Recent $CARA technical alerts: New Uptrend plus 7 more alerts... https://t.co/fyIsqa3hPp January 7th 2019, 1:01pm |
|
@AlexBo6 $CARA #trade good news #korsuva January 7th 2019, 12:01pm |
|
@bbnsnews Zacks: Analysts Anticipate Cara Therapeutics Inc $CARA Will Post Quarterly Sales of $3.35 Million https://t.co/TXr3MxwpiM January 7th 2019, 10:01am |
 |
@MarijuanaStocks $CARA Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA™ https://t.co/VQ3PSgvLE2 January 7th 2019, 7:01am |
|
@BioStocks $CARA Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA Injection in Hemodialysis Patients with Pruritus. Topline Data Q2 January 7th 2019, 7:01am |
 |
@RyanSTTrader $CARA This company is pure dogsh*t - we don’t care for the theatrics anymore and management spin PR jobs are getting stale January 7th 2019, 7:01am |
 |
@odibro $CARA Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA™ (CR845/ difelikefalin) Injection in Hemodial… https://t.co/63TiqYIn8a January 7th 2019, 7:01am |
 |
@ZolmaxNews Insider Selling: Cara Therapeutics Inc $CARA CEO Sells $272,200.00 in Stock https://t.co/JfMiRjWkLX January 7th 2019, 5:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.